KPV Peptide: The alpha-MSH Derivative Revolutionizing Gut and Skin Health
Discover the benefits of KPV peptide for gut and skin health. Learn about its mechanism of action, clinical research, and the upcoming July 2026 FDA PCAC review.
The Peptide Chronicle
Science, Policy & Truth
Objective, peer-reviewed reporting on therapeutic peptides, regulatory updates, clinical trial results, and scientific consensus. No hype. No product sales.
Latest Articles
Recent Posts
Recent evidence-based coverage of peptide science, regulation, clinical research, and misinformation.
Thymosin Alpha-1: Precision Immune Modulation and Global Clinical Use
Thymosin Alpha-1 (thymalfasin) 2026 clinical primer: mechanism as a precision immunomodulator, key trial data in hepatitis, oncology, sepsis and COVID-19, safety profile, and U.S. compounding reclassification (503A Category 2).
Semax vs. Selank: The 2026 Science-Backed Guide to Cognitive Peptides
Semax or Selank? Explore the 2026 clinical science comparing these two powerful neurocognitive peptides for anxiety relief, focus, memory, and brain health.
NMN vs. NR: The 2026 Clinical Verdict on the Ultimate NAD+ Precursor
NMN or NR? Discover the landmark 2026 human clinical trial results comparing these ultimate NAD+ precursors for mitochondrial health and cellular longevity.
FDA Peptides Advisory Committee 2026: Inside the Upcoming Compounding Review and the Science of Epithalon
The FDA is convening an Advisory Committee to review compounded peptides. Discover what this means for Epithalon, BPC-157, and the future of longevity medicine.
MOTS-c Exercise Mimetic Peptide: The Science of Mitochondrial Signaling in 2026
What is MOTS-c? Discover the science behind the MOTS-c exercise mimetic peptide, its role in insulin sensitivity, mitochondrial health, and 2026 research updates.
GHK-Cu Copper Peptide Benefits: The Science of Skin and Hair Regeneration in 2026
Discover the scientific GHK-Cu copper peptide benefits for skin barrier repair and hair growth. Learn the biological mechanisms and clinical evidence.
Elecoglipron: Once-Daily Oral GLP-1 Pill for Weight Loss
What is elecoglipron and how does it work? Dr. Ashford breaks down the Lancet's VISTA and SOLSTICE Phase IIb trials for weight loss and diabetes.
Injectable Peptides Safety: Social Media Stacks Explained
Are injectable peptide stacks safe? Dr. Ashford explains GLP-1 evidence, BPC-157 and TB-500 gaps, and social-media peptide risks.
Peptide Paradox: Unregulated vs. FDA-Approved Peptides Explained
Navigate the peptide paradox: understand the risks of unregulated peptides like BPC-157 vs. the science behind FDA-approved GLP-1s for weight loss and diabetes.
GLP-1 Peptide Exercise Decline: ENDO 2026 Muscle Warning
GLP-1 peptide exercise decline is the new ENDO 2026 warning: users lost weight but took fewer steps, making muscle protection essential for success now.
Ozempic Lizard Venom: Exendin-4, GLP-1 Drugs and Peptide Science
Is Ozempic lizard venom? Learn the real exendin-4 story, how GLP-1 peptide drugs evolved, and what social media gets wrong about peptides today right now.
GLP-1s, Retatrutide, and Knee Osteoarthritis: Peptide Science in 2026
GLP-1 drugs and retatrutide are being studied for knee osteoarthritis pain and joint outcomes. Learn what is promising, limited, and still unproven.
Retatrutide Phase 3: Why the Triple-G Peptide Is Suddenly Everywhere
Retatrutide phase 3 weight-loss results explained, including its triple GIP, GLP-1 and glucagon mechanism and why weight management matters for orthopedic patients.
The "Wolverine Stack": Why BPC-157 and TB-500 are Dominating Recovery Science in 2026
Comprehensive guide to the BPC-157 and TB-500 'Wolverine Stack' for injury recovery and tissue repair in 2026.
Peptides for Men's Health: The 2026 Guide to Metabolic Optimization and Longevity
Comprehensive guide to peptides for men's health in 2026, focusing on metabolic optimization, visceral fat reduction, and recovery science.
FDA Peptide Reclassification 2026: The Peptide Renaissance for Therapeutic Peptides
Understand the FDA peptide reclassification 2026. Learn about BPC-157, MOTS-c, and other peptides, their impact on access, safety, and the future of peptide therapy.
Enicepatide and Petrelintide: Next-Generation Weight Loss Peptides Explained
Enicepatide CT-388 and petrelintide explained: why GLP-1/GIP and amylin analog weight-loss peptides are trending after Roche’s ADA 2026 obesity update.
No articles match that search.